MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Validation of smartphone-based active tests with structural neuroimaging in Huntington’s disease

    J. Rennig, S. Holiga, D. Hawellek, F. Lipsmeier, J. Dorn, S. Schobel, C. Simillion, M. Lindemann (Basel, Switzerland)

    Objective: Explore the association of smartphone-based active tests in the Roche Huntington’s disease (HD) Digital Monitoring Platform (dMP) with brain imaging. Background: Remote digital monitoring…
  • MDS Virtual Congress 2021

    Intergenerational repeat instability of TTTCA expansions in SAMD12 might be the major cause of the genetic anticipation in familial cortical myoclonic tremor with epilepsy

    ZD. Cen, XH. Chen, HT. Wang, DH. Yang, F. Zhang, Y. Chen, S. Chen, LB. Wang, P. Liu, F. Xie, B. Wang (Hangzhou, China)

    Objective: To delineate and analyze the relationship between genetic and clinical features in 78 patients from 23 familial cortical myoclonic tremor with epilepsy type 1 (FCMTE1) pedigrees. Background:…
  • MDS Virtual Congress 2021

    Cerebellar bioenergetic depletion following ubiquinol supplementation in a patient with COQ8A-related ataxia

    J. Prasuhn, M. Göttlich, B. Ebeling, C. Bodemann, S. Großer, I. Wellach, K. Reuther, H. Hanssen, N. Brüggemann (Lübeck, Germany)

    Objective: To non-invasively map the individual treatment response in a patient with COQ8A-related ataxia following coenzyme Q10 supplementation. Background: Primary coenzyme Q10 (CoQ10) deficiency is…
  • MDS Virtual Congress 2021

    Electrophysiological testing aids the diagnosis of tremor versus myoclonus in clinically challenging patients

    C. Everlo, JW. Elting, M. Tijssen, M. V.D. Stouwe (Groningen, Netherlands)

    Objective: We investigated how clinical electrophysiological testing can help to distinguish tremor versus myoclonus. Background: Tremor is the most common movement disorder and myoclonus its…
  • MDS Virtual Congress 2021

    Facial Paralysis Associated with COVID-19: a systematic review.

    B. Franco, G. Aragão, M. Pereira, I. Vasconcelos, A. Nunes, C. Filho (Salvador, Brazil)

    Objective: To develop an overview of facial paralysis associated with COVID-19 to identify the clinical pattern, other symptoms, disease severity, besides discussing epidemiologic characteristics. Background:…
  • MDS Virtual Congress 2021

    PERCEPTION OF INDIVIDUALS WITH PARKINSON´S DISEASE ABOUT ISOLATION DURING THE COVID-19 PANDEMIC

    R. Pasquarelli Volpe, L. Laskovski, S. Mahmoud Smaili (Londrina, Brazil)

    Objective: To explore the knowledge of individuals with PD about COVID-19's world pandemic, and to investigate their perception about its impacts and consequences. Background: The…
  • MDS Virtual Congress 2021

    Patterns of Improvement with Valbenazine in Patients with Tardive Dyskinesia

    C. Correll, T. Carmack, C. Shah, L. Lundt (Glen Oaks, USA)

    Objective: To characterize different patterns of improvement with valbenazine (VBZ) in patients with tardive dyskinesia (TD) using Abnormal Involuntary Movement Scale (AIMS) data from KINECT…
  • MDS Virtual Congress 2021

    Telephone Visit Efficacy for Parkinson’s Disease During the COVID-19 Pandemic

    F. Abu Ahmad, R. Postuma (Montreal, Canada)

    Objective: To compare telephone and in-person visits in the clinical care of Parkinson’s disease (PD) patients. Background: There has been growing interest in using telemedicine…
  • MDS Virtual Congress 2021

    Home Health Management of Parkinson’s Disease Deep Brain Stimulation: A Randomized Clinical Trial

    G. Duffley, A. Wright, C. Hess, A. Ramirez-Zamora, P. Zeilman, S. Chiu, A. Szabo, B. Lutz, K. Foote, M. Okun, C. Butson (Salt Lake City, USA)

    Objective: Evaluate the efficacy of home health DBS postoperative management in an effort to reduce travel burden and improve access. Background: The travel required to…
  • MDS Virtual Congress 2021

    Should Amantadine DR/ER Be Considered Prior to Device-Aided Therapies for Parkinson’s Disease?

    R. Hauser, S. Goud, A. Formella (Tampa, USA)

    Objective: Evaluate delayed release/extended release amantadine (AMT DR/ER) capsules for motor complications in patients meeting 5-2-1 criteria for device-aided therapies (DAT) in advanced Parkinson disease.…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 132
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley